-
006734 Hepatitis A Antibody, IgM (Hep A Ab, IgM) Description: This test detects the presence of IgM antibodies to the hepatitis A virus (HAV) in the blood. IgM antibodies are usually the first type of antibody produced by the immune system when a virus attacks. A positive result indicates a recent HAV infection. Interpretation: Positive: Recent infection with hepatitis A virus. Negative: No recent HAV infection. Use: Used to diagnose acute hepatitis A infection. It helps differentiate between acute and past infections and is crucial in the management of outbreaks and individual cases of hepatitis A.
-
Hepatitis C Virus Antibody (Hep C Virus Ab) Description: This test looks for antibodies to the hepatitis C virus (HCV) in the blood, indicating HCV exposure. It does not distinguish between current or past infection. Interpretation: Positive: HCV exposure; further testing with HCV RNA is needed to determine if the infection is current. Negative: No evidence of HCV exposure. Use: Screening for HCV infection. Positive results prompt further testing to confirm active infection and guide treatment.
-
HBsAg (Hepatitis B Surface Antigen) Detection Test Description: This test detects the presence of hepatitis B surface antigen (HBsAg) in the blood. The presence of HBsAg indicates that the person is infectious and may have acute or chronic hepatitis B virus (HBV) infection. Interpretation: Positive: Current hepatitis B infection (acute or chronic). Negative: No current hepatitis B infection. Use: Used for the early diagnosis of HBV infection and to monitor the infectious status of individuals. It is also a key marker for vaccination efficacy.
-
Hepatitis B Core Ab, IgM Description: This test detects IgM antibodies to hepatitis B core antigen (HBcAg). The presence of these antibodies indicates recent HBV infection. Interpretation: Positive: Recent HBV infection, usually indicating an acute infection. Negative: No recent infection. Use: This test helps distinguish between acute and chronic HBV infections and is used in conjunction with other hepatitis B markers to provide a complete diagnosis.
Clinical Practice Use: These tests are integral to diagnosing and managing hepatitis infections, guiding treatment decisions, and informing public health responses. They are used in a variety of clinical settings, including:
Screening: For individuals at risk for hepatitis infection (due to lifestyle, occupational exposure, or known exposure to the virus). Diagnosis: For patients presenting with symptoms of hepatitis (e.g., jaundice, fatigue, abdominal pain). Monitoring: To evaluate treatment effectiveness and to monitor chronic infections. Preventive care: In vaccination programs and for screening blood donations.
